scientific-storytelling
(4)
The Biotech Story Usually Breaks Before the Science Does
A promising molecule can survive a bad metaphor. A young biotech usually cannot. SCIENT built its business around the awkward, consequential work of making complicated science understandable before the next investor meeting, clinical milestone, or corporate turning point.
When Public Relations Became Too Small for LifeSci
The agency began with a narrow label and kept adding jobs until the label broke. Its answer is a useful lesson in how to sell difficult science: put the people who understand it beside the people who know how to make others care.
The Medical Meeting That Wouldn’t Stay Small
One advisory board, a folding table and 3,000 envelopes became a 25-year medical communications company. JB Ashtin’s real product is the thing agencies rarely put on an invoice: trust under pressure.
The Scientists Had the Breakthrough. TellMed Had to Make Anyone Care.
A New Jersey agency found a business in the awkward distance between a scientific result and a human reaction. Its product is not publicity so much as translation - with enough regulatory discipline to survive the trip.